TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
30/09/2025
Voltar para busca
Dado oficial do USPTO
NANOBIOTIX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
NANOBIOTIX
ST13
US500000079107530Classe
5, 10, 42, 44
Pedido
79107530
Registro
4248032
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
08/10/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 42, 44
Data de depósito
09/11/2011
Data de registro
27/11/2012
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/06/2023
Última transação
08/10/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Paris, FR
Examinador
MURRAY,DAVID T
Unidade examinadora
M40
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
Nanobiotix
Nanobiotix
Representantes
Paul Cosmovici
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Preparations for medical use particularly for the diagnosis and treatment of tumors; preparations for medical use particularly for the diagnosis and treatment of tumors using radiation treatment; radioactive substances for medical use for the diagnosis and treatment of tumors using radiation treatment; radiological contrast substances for medical use; chemical reagents for medical use; bacteriological preparations for medical use; enzymes for medical use; enzyme preparations for medical use; diagnostic preparations for medical use; antibiotics; antiseptics; health care preparations for treating cancer; biological preparations for medical use for the treatment of cancer; chemical preparations for medical or pharmaceutical use particularly for use in treating cancer; drugs for medical use for use in the treatment of cancer; medicines for human purposes for use in the treatment of cancer; restorative medicine for use in the treatment of oncological diseases; chemical-pharmaceutical preparations for use in treating oncological disease and disorders; pharmaceutical preparations for use in treating oncological disease and disorders
Classe 10
Apparatus for use in medical analysismedical X-ray apparatusdiagnostic apparatus for medical usemedical X-ray apparatus; radiology screens for medical use; X-ray photographs for medical purposes; medical X-ray apparatus and installationsmounts for the production of X-raysfor medical use; X-ray protection devices for medical useradiology screens; special furniture for medical usetherapeutic mattressesbedsseats and cushions
Classe 42
Scientific and technological servicesresearch and design services in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications for use in nanomedicine which is nanotechnology applied to medicine; scientific and technological evaluationsestimates and investigations provided by engineersresearchers in the field of nanomedicine; technical project studiestechnical research in the field of nanomedicine; industrial analysis and research services in the field of nanomedicine; chemistry serviceschemistry consultation; expert appraisals in the field of engineeringconsultation in the field of engineering; technical research in the field of nanomedicine
Classe 44
Health services particularly in the field of nanomedicineuse of nanomedicine in disease management programs; medical services particularly in the field of nanomedicineuse of nanomedicine in disease management programs
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30/09/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30/09/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
23/06/2023
71AG
REGISTERED-SEC.71 ACCEPTED
23/06/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/06/2023
ES71
TEAS SECTION 71 RECEIVED
25/11/2022
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
27/11/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
26/11/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
17/07/2019
71AG
REGISTERED-SEC.71 ACCEPTED
17/07/2019
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
04/07/2019
PR71
POST REGISTRATION ACTION MAILED - SEC.71
17/01/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
17/01/2019
ES71
TEAS SECTION 71 RECEIVED
27/11/2018
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
27/11/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/04/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/03/2013
FIMP
FINAL DISPOSITION PROCESSED
09/03/2013
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
27/02/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
27/11/2012
GPNX
NOTIFICATION PROCESSED BY IB
16/10/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/09/2012
PUBO
PUBLISHED FOR OPPOSITION
11/09/2012
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
22/08/2012
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
22/08/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/08/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/08/2012
ALIE
ASSIGNED TO LIE
09/08/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/07/2012
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/07/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/07/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/07/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/07/2012
RFNT
REFUSAL PROCESSED BY IB
27/03/2012
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/03/2012
RFRR
REFUSAL PROCESSED BY MPU
05/03/2012
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/03/2012
CNRT
NON-FINAL ACTION WRITTEN
01/03/2012
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
01/03/2012
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/03/2012
CNRT
NON-FINAL ACTION WRITTEN
29/02/2012
DOCK
ASSIGNED TO EXAMINER
27/02/2012
MAFR
APPLICATION FILING RECEIPT MAILED
17/01/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/01/2012
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/01/2012
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NANOBIOTIX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.